MedTrace Logo

Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes

NCT03875469 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 425

Last updated 2021-03-03

No results posted yet for this study

Summary

This study investigates if a new medical device, which injects contrast media and flushing solution into humans to increase the visibility of images taken of the human body for diagnostic purposes, is easier to handle, quicker and cheaper than an older injector.

Conditions

  • Computed Tomography

Interventions

DEVICE

Centargo injector (BPI 1000045)

Contrast-enhanced computer tomography conducted with Centargo injector

DEVICE

Stellant MP injector

Contrast-enhanced computer tomography conducted with Stellant MP injector

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-21
Primary Completion
2020-03-10
Completion
2020-03-10

Countries

  • Australia
  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03875469 on ClinicalTrials.gov